Lates News

Dogwood Therapeutics (DWTX.US) reported revenue of 0 US dollars in Q3 2025, the same as the previous value; earnings per share were -8.20 US dollars, compared to -2.05 US dollars in the previous period, and the expected value was -1.44 US dollars.